EpiBiologics

GlycoEra

This company develops glycoengineered biologics to degrade disease-causing extracellular proteins for patients with autoimmune disorders and other inflammatory conditions.

Laigo Bio

This company develops bispecific antibody therapies that remove disease-causing membrane proteins to treat patients with cancer and autoimmune disorders.

Epana Bio

This company develops precision T-cell engagers and biologics using artificial intelligence and genomics to treat patients with autoimmune diseases.

Lycia Therapeutics

The company develops extracellular protein-degrading therapeutics for patients with autoimmune, inflammatory and allergic diseases.

InduPro

This biotechnology company develops proximity-based protein therapeutics for patients with cancer and autoimmune diseases.

Avilar Therapeutics

The company develops extracellular protein degraders to treat autoimmune and neurological diseases for patients and healthcare providers.

Hummingbird Bioscience

This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.

Attovia Therapeutics

The company develops biparatopic biologics to treat patients with immune-mediated diseases and cancer through a modular protein design platform.